Nebenwirkungen · Mirvaso
Mirvaso 3 mg/g gel · Abschnitt 4.8 · PDF-Seite 5
HOS-127971 · Präparat HOS-096493
Tabulated list of adverse reactions The adverse reactions are classified by System Organ Class and frequency, using the following convention: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to <1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the available data) and were reported with Mirvaso either in clinical studies, or during the post-marketing experience (identified by an asterix (*) in Table 1).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-15T13:53:00Z · SHA-256 9c7e643a7b3870885a0241d066a8ccdd78ce3d5940f001edca4fc861c64df7e0 · Passage 17f690b54ab0c5e020c4a0017a3bc8dc121c31c12ce16ab9b3d6d948a26631e9 · Zeichen 433–910 im Abschnitt